MyAverix Finance
SHG · Healthcare
Jianmin Pharmaceutical Group Co Ltd (600976)
Drug Manufacturers - Specialty & Generic
Jianmin Pharmaceutical Group Co Ltd (600976) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $5.11B, P/E ratio is 14.05, net margin is 10.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600976
Jianmin Pharmaceutical Group Co Ltd (600976) — FAQ
What is Jianmin Pharmaceutical Group Co Ltd's market cap?
Jianmin Pharmaceutical Group Co Ltd (600976) has a reported market cap of $5.11B (data as of 2026-03-28).
What is 600976's P/E ratio?
The price-to-earnings (P/E) ratio for Jianmin Pharmaceutical Group Co Ltd (600976) is 14.05 (data as of 2026-03-28).
Does Jianmin Pharmaceutical Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jianmin Pharmaceutical Group Co Ltd (600976). Check the MyAverix Finance app for the latest dividend data.
What sector is Jianmin Pharmaceutical Group Co Ltd in?
Jianmin Pharmaceutical Group Co Ltd (600976) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600976 listed on?
600976 is listed on SHG.
What is Jianmin Pharmaceutical Group Co Ltd's net margin?
Jianmin Pharmaceutical Group Co Ltd (600976) reports a net margin of 10.7% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.